The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men
Purpose. Fragility fractures in men constitute a major worldwide public health problem with a life-time risk of 13%. It cannot be directly inferred that antiosteoporotic drugs effective in women have the same effect in men. Our aim was to appraise the existing evidence for efficacy of osteoporosis t...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Journal of Osteoporosis |
| Online Access: | http://dx.doi.org/10.4061/2011/259818 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562702867759104 |
|---|---|
| author | Peter Schwarz Niklas Rye Jorgensen Leif Mosekilde Peter Vestergaard |
| author_facet | Peter Schwarz Niklas Rye Jorgensen Leif Mosekilde Peter Vestergaard |
| author_sort | Peter Schwarz |
| collection | DOAJ |
| description | Purpose. Fragility fractures in men constitute a major worldwide public health problem with a life-time risk of 13%. It cannot be directly inferred that antiosteoporotic drugs effective in women have the same effect in men. Our aim was to appraise the existing evidence for efficacy of osteoporosis treatment in men. Methods. This study was a systematic review of the published literature on the clinical efficacy of medical osteoporosis therapy in the reduction of fracture risk in men (age > 50 years). Studies included were randomised, placebo-controlled trials of men. Results. Five BMD studies of antiresorptive treatment were included. All studies showed an increase in BMD, but there was only a nonsignificant trend in the reduction of clinical fractures. Three BMD studies of anabolic treatment with teriparatide were also included. These showed a significant mean increase in spine BMD and for vertebral fractures a non-significant trend towards a reduction was seen. Conclusion. The evidence of medical osteoporosis treatment in men is scant and inconclusive due to the lack of prospective RCT studies with fracture prevention as primary end point. So far, all evidence is based on BMD increases in small RCT studies showing BMD increases comparable to those reported in postmenopausal women. |
| format | Article |
| id | doaj-art-d4731e422a4c486bac13dbf644115326 |
| institution | Kabale University |
| issn | 2042-0064 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Osteoporosis |
| spelling | doaj-art-d4731e422a4c486bac13dbf6441153262025-02-03T01:22:03ZengWileyJournal of Osteoporosis2042-00642011-01-01201110.4061/2011/259818259818The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in MenPeter Schwarz0Niklas Rye Jorgensen1Leif Mosekilde2Peter Vestergaard3Research Center of Aging and Osteoporosis, Department of Medicine, Glostrup Hospital, 2600 Glostrup, DenmarkResearch Center of Aging and Osteoporosis, Department of Medicine, Glostrup Hospital, 2600 Glostrup, DenmarkDepartment of Endocrinology and Internal Medicine, MEA, THG, Aarhus University Hospital, DenmarkDepartment of Endocrinology and Internal Medicine, MEA, THG, Aarhus University Hospital, DenmarkPurpose. Fragility fractures in men constitute a major worldwide public health problem with a life-time risk of 13%. It cannot be directly inferred that antiosteoporotic drugs effective in women have the same effect in men. Our aim was to appraise the existing evidence for efficacy of osteoporosis treatment in men. Methods. This study was a systematic review of the published literature on the clinical efficacy of medical osteoporosis therapy in the reduction of fracture risk in men (age > 50 years). Studies included were randomised, placebo-controlled trials of men. Results. Five BMD studies of antiresorptive treatment were included. All studies showed an increase in BMD, but there was only a nonsignificant trend in the reduction of clinical fractures. Three BMD studies of anabolic treatment with teriparatide were also included. These showed a significant mean increase in spine BMD and for vertebral fractures a non-significant trend towards a reduction was seen. Conclusion. The evidence of medical osteoporosis treatment in men is scant and inconclusive due to the lack of prospective RCT studies with fracture prevention as primary end point. So far, all evidence is based on BMD increases in small RCT studies showing BMD increases comparable to those reported in postmenopausal women.http://dx.doi.org/10.4061/2011/259818 |
| spellingShingle | Peter Schwarz Niklas Rye Jorgensen Leif Mosekilde Peter Vestergaard The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men Journal of Osteoporosis |
| title | The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men |
| title_full | The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men |
| title_fullStr | The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men |
| title_full_unstemmed | The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men |
| title_short | The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men |
| title_sort | evidence for efficacy of osteoporosis treatment in men with primary osteoporosis a systematic review and meta analysis of antiresorptive and anabolic treatment in men |
| url | http://dx.doi.org/10.4061/2011/259818 |
| work_keys_str_mv | AT peterschwarz theevidenceforefficacyofosteoporosistreatmentinmenwithprimaryosteoporosisasystematicreviewandmetaanalysisofantiresorptiveandanabolictreatmentinmen AT niklasryejorgensen theevidenceforefficacyofosteoporosistreatmentinmenwithprimaryosteoporosisasystematicreviewandmetaanalysisofantiresorptiveandanabolictreatmentinmen AT leifmosekilde theevidenceforefficacyofosteoporosistreatmentinmenwithprimaryosteoporosisasystematicreviewandmetaanalysisofantiresorptiveandanabolictreatmentinmen AT petervestergaard theevidenceforefficacyofosteoporosistreatmentinmenwithprimaryosteoporosisasystematicreviewandmetaanalysisofantiresorptiveandanabolictreatmentinmen AT peterschwarz evidenceforefficacyofosteoporosistreatmentinmenwithprimaryosteoporosisasystematicreviewandmetaanalysisofantiresorptiveandanabolictreatmentinmen AT niklasryejorgensen evidenceforefficacyofosteoporosistreatmentinmenwithprimaryosteoporosisasystematicreviewandmetaanalysisofantiresorptiveandanabolictreatmentinmen AT leifmosekilde evidenceforefficacyofosteoporosistreatmentinmenwithprimaryosteoporosisasystematicreviewandmetaanalysisofantiresorptiveandanabolictreatmentinmen AT petervestergaard evidenceforefficacyofosteoporosistreatmentinmenwithprimaryosteoporosisasystematicreviewandmetaanalysisofantiresorptiveandanabolictreatmentinmen |